Maternal and umbilical cord blood level of macrophage migration inhibitory factor and insulin like growth factor in Sudanese women with preeclampsia

References

• ACOG Committee on Obstetric Practice. 2002. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists. International Journal of Gynaecology and Obstetrics 77:67–75.
   PubMed Web of Science ®Google Scholar
• Alshareef SA, Eltom AM, Nasr AM, Hamdan HZ, Adam I. 2017. Rubella, herpes simplex virus type 2 and preeclampsia. Virology Journal 14:142.
   PubMed Web of Science ®Google Scholar
• Bakheit KH, Bayoumi NK, Eltom AM, Elbashir MI, Adam I. 2009. Cytokines profiles in Sudanese women with preeclampsia. Hypertension in Pregnancy 28:224–229.
   PubMed Web of Science ®Google Scholar
• Bakheit KH, Ghebremeskel K, Zaiger G, Elbashir MI, Adam I. 2010. Erythrocyte antioxidant enzymes and plasma antioxidant vitamins in Sudanese women with pre-eclampsia. Journal of Obstetrics and Gynaecology (Lahore) 30:147–150.
   Web of Science ®Google Scholar
• Bilano VL, Ota E, Ganchimeg T, Mori R, Souza JP. 2014. Risk factors of pre-eclampsia/eclampsia and its adverse outcomes in low- and middle-income countries: a WHO secondary analysis. PLoS One 9:e91198.
   PubMed Web of Science ®Google Scholar
• Calandra T, Roger T. 2003. Macrophage migration inhibitory factor: a regulator of innate immunity. Nature Reviews Immunology 3:791–800.
   PubMed Web of Science ®Google Scholar
• Cardaropoli S, Ietta F, Romagnoli R, Rolfo A, Paulesu L, Todros T, et al. 2014. Lower macrophage migration inhibitory factor concentrations in maternal serum before pre-eclampsia onset. Journal of Interferon and Cytokine Research 34:537–542.
   PubMed Web of Science ®Google Scholar
• Cardaropoli S, Paulesu L, Romagnoli R, Ietta F, Marzioni D, Castellucci M, et al. 2012. Macrophage migration inhibitory factor in fetoplacental tissues from preeclamptic pregnancies with or without fetal growth restriction. Clinical and Developmental Immunology 2012:1–9.
   Google Scholar
• Catarino C, Santos-Silva A, Belo L, Rocha-Pereira P, Rocha S, Patrício B, et al. 2012. Inflammatory disturbances in preeclampsia: relationship between maternal and umbilical cord blood. Journal of Pregnancy 2012:1.
   Google Scholar
• Elhaj ET, Adam I, Alim A, Elhassan EM, Lutfi MF. 2015. Thyroid function/antibodies in Sudanese patients with preeclampsia. Front Endocrinol (Lausanne). 6:87.
   PubMed Web of Science ®Google Scholar
• Elhassan EM, Mirghani OA, Adam I. 2009. High maternal mortality and stillbirth in the Wad Medani Hospital, Central Sudan, 2003-2007. Tropical Doctor 39:238–239.
   PubMed Web of Science ®Google Scholar
• Elzein HO, Muddathir ARM, Rida M, Rayis DA, Elhassan EM, Adam I, et al. 2016. Fibrinolysis parameters in Sudanese women with severe preeclampsia. Hypertension in Pregnancy 35:559–564.
   PubMed Web of Science ®Google Scholar
• Halhali A, Díaz L, Barrera D, Avila E, Larrea F. 2014. Placental calcitriol synthesis and IGF-I levels in normal and preeclamptic pregnancies. Journal of Steroid Biochemistry and Molecular Biology 144:44–49.
   PubMed Web of Science ®Google Scholar
• Hristoskova S, Holzgreve W, Zhong XY, Hahn S. 2006. Macrophage migration inhibition factor is elevated in pregnancy, but not to a greater extent in preeclampsia. Archives of Gynecology and Obstetrics 274:25–28.
   PubMedGoogle Scholar
• Järvisalo MJ, Juonala M, Raitakari OT. 2006. Assessment of inflammatory markers and endothelial function. Current Opinion in Clinical Nutrition and Metabolic Care 9:547–552.
   PubMed Web of Science ®Google Scholar
• Jones JI, Clemmons DR. 1995. Insulin-like growth factors and their binding proteins: biological actions. Endocrine Reviews 16:3–34.
   PubMed Web of Science ®Google Scholar
• Kharb S, Panjeta P, S. Ghalaut V, Bala J, Nanda S. 2016. Biomarkers in preeclamptic women with normoglycemia and hyperglycemia. Current Hypertension Reviews 12:228–233.
   PubMed Web of Science ®Google Scholar
• Liao S, Vickers MH, Taylor RS, Jones B, Fraser M, McCowan LME, et al. 2017. Maternal serum IGF-1, IGFBP-1 and 3, and placental growth hormone at 20weeks’ gestation in pregnancies complicated by preeclampsia. Pregnancy Hypertension 10:149–154.
   PubMed Web of Science ®Google Scholar
• Olmos A, Díaz L, Avila E, Barrera D, López-Marure R, Biruete B, et al. 2013. Associations between insulin-like growth factor I, vascular endothelial growth factor and its soluble receptor 1 in umbilical serum and endothelial cells obtained from normotensive and preeclamptic pregnancies. Growth Factors 31:123–129.
   PubMed Web of Science ®Google Scholar
• Peng H, Xue M, Xia A. 2011. Study on changes of IGF-I and leptin levels in serum and placental tissue of prceclampsia patients and their associativity. Chinese Journal of Cellular and Molecular Immunology 27:192–194.
   Google Scholar
• Sifakis S, Akolekar R, Kappou D, Mantas N, Nicolaides KH. 2010. Maternal serum insulin-like growth factor-I at 11-13 weeks in preeclampsia. Prenatal Diagnosis 30:1026–1031.
   PubMed Web of Science ®Google Scholar
• Todros T, Bontempo S, Piccoli E, Ietta F, Romagnoli R, Biolcati M, et al. 2005. Increased levels of macrophage migration inhibitory factor (MIF) in preeclampsia. European Journal of Obstetrics and Gynecology and Reproductive Biology 123:162–166.
   PubMed Web of Science ®Google Scholar
• Troeger C, Holzgreve W, Ladewig A, Zhong XY, Hahn S. 2006. Examination of maternal plasma erythropoietin and activin A concentrations with regard to circulatory erythroblast levels in normal and preeclamptic pregnancies. Fetal Diagnosis and Therapy 21:156–160.
   PubMed Web of Science ®Google Scholar
• Wang A, Rana S, Karumanchi SA. 2009. Preeclampsia: the role of angiogenic factors in its pathogenesis. Physiology (Bethesda) 24:147–158.
   PubMed Web of Science ®Google Scholar